NEWS

Peptide therapy news

Regulatory moves, FDA actions, new research and what the industry does about it. The reporting lives on our editorial hub, PeptideWellness — every headline below opens there.

INDUSTRY

GLP-1 muscle loss: what Nestle's new push reveals

Nestle says it is building products for people on Ozempic and Wegovy, starting with the muscle they lose. The loss is real and well measured — but only one intervention reliably reduces it.

August 18, 2026 / 9 min read · on PeptideWellness ↗

ENFORCEMENT